Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
NCT01847014
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
Protocol-defined criterion of macitentan availability achieved.
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Macitentan
Sponsor
Actelion